Beyond weight reduction, the same trial reported several additional metabolic outcomes as secondary or exploratory endpoints: Improved glycaemic control reductions in HbA1c levels were observed in participants with type 2 diabetes in a separate Phase 2 cohort [3] [4] Reduced waist circumference suggesting a decrease in visceral (abdominal) fat, which is associated with cardiovascular risk Improvements in lipid profiles including reductions in triglycerides Potential signal for benefit in metabolic-associated steatotic liver disease (MASLD) based on the glucagon receptor's proposed role in hepatic fat metabolism
GHK-Cu + AHK-Cu Body Wash (8 oz): A rich, moisturizing body wash that cleanses and helps achieve smooth, radiant skin
Beyond appetite suppression, GLP-1 drugs slow how quickly food moves from your stomach into your intestines, keeping you feeling full longer after meals
Learn more in our article Is Ozempic the Same as Semaglutide
doi: 10.1155/2019/4831967 84 HouLDuJDongYWangMWangLZhaoJ
This is particularly valuable for retatrutide users, given that the standard escalation protocol calls for relatively aggressive increases every four weeks